Foghorn Therapeutics (FHTX) Earnings Date & Reports

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

FHTX is expected to report earnings to fall 16.52% to -19 cents per share on May 12

Foghorn Therapeutics FHTX Stock Earnings Reports

Q1'25

Est.

$-0.19

Q4'24

Beat

by $0.12

Q3'24

Beat

by $0.12

Q2'24

Beat

by $0.19

Q1'24

Beat

by $0.03

The last earnings report on March 06 showed earnings per share of -23 cents, beating the estimate of -34 cents. With 31.26K shares outstanding, the current market capitalization sits at 235.80M.

View a ticker or compare two or three

Compare

FHTX